Zaremba Rabourn Amy — SEC Form 4 filings
SEC reporting owner CIK 1832343. 9 Form 4 filings on record with FilingPulse; latest filed 2026-04-27.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-01-12 to 2026-04-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 4,457 shares, $23,310 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: sale of 2,816 shares @ $5.25 ($14,770) in Opus Genetics, Inc., filed 2026-03-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Opus Genetics, Inc. (IRD) | Head of Fin. Quality Assurance | 9 | — | 2 legs · 4,457 sh · $23,310 | 9 |
Form 4 filings — Zaremba Rabourn Amy
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-27 | 4 | Opus Genetics, Inc. (IRD) | Sale (S): 1,641 @ $5.20 | EDGAR |
| 2026-03-18 | 4 | Opus Genetics, Inc. (IRD) | Sale (S): 2,816 @ $5.25 | EDGAR |
| 2026-01-26 | 4 | Opus Genetics, Inc. (IRD) | Grant/award (A): 86,500 @ $0 | EDGAR |
| 2026-01-21 | 4 | Opus Genetics, Inc. (IRD) | Tax withholding (F): 3,390 @ $2.10 | EDGAR |
| 2026-01-13 | 4 | Opus Genetics, Inc. (IRD) | Tax withholding (F): 3,950 @ $1.93 | EDGAR |
| 2025-03-17 | 4 | Opus Genetics, Inc. (IRD) | Grant/award (A): 39,500 @ $0 · Grant/award (A): 39,500 (derivative) @ $0 | EDGAR |
| 2025-02-06 | 4 | Opus Genetics, Inc. (IRD) | Tax withholding (F): 8,190 @ $1.14 | EDGAR |
| 2024-01-22 | 4 | Ocuphire Pharma, Inc. (OCUP) | Grant/award (A): 40,000 @ $0 · Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-01-12 | 4 | Ocuphire Pharma, Inc. (OCUP) | Tax withholding (F): 3,950 @ $3.27 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1832343 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →